Contributo scientifico, sviluppato generalmente su uno specifico argomento, che illustra risultati originali di una ricerca o presenta caratteristiche di review, cioè di discussione dello stato dell’arte o della letteratura entro un ambito scientifico definito. La rivista di pubblicazione deve presentare caratteristiche di scientificità. La tipologia non comprende editoriali, commenti brevi, repliche, abstract, errata, recensioni e prodotti similari, per i quali sono previste specifiche tipologie.
Phosphatidylinositol 3-kinase inhibition potentiates glucocorticoid response in B-cell acute lymphoblastic leukemia
2018 Evangelisti, C; Cappellini, A; Oliveira, M; Fragoso, R; Barata, Jt; Bertaina, A; Locatelli, F; Simioni, C; Neri, Lm; Chiarini, F; Lonetti, A; Buontempo, F; Orsini, E; Pession, A; Manzoli, L; Martelli, Am; Evangelisti, C.
Age-Related Alterations Affecting the Chondrogenic Differentiation of Synovial Fluid Mesenchymal Stromal Cells in an Equine Model
2019 Mazzotti, E; Teti, G; Falconi, M; Chiarini, F; Barboni, B; Mazzotti, A; Muttini, A.
Enhancing the effectiveness of nucleoside analogs with mTORC1 blockers to treat acute myeloid leukemia patients
2013 Martelli, Am; Lonetti, A; Amadori, S; Mccubrey, Ja; Chiarini, F
Therapeutic targeting of CK2 in acute and chronic leukemias
2018 Buontempo, F; Mccubrey, Ja; Orsini, E; Ruzzene, M; Cappellini, A; Lonetti, A; Evangelisti, C; Chiarini, F; Evangelisti, C; Barata, Jt; Martelli, Am.
Two hits are better than one: targeting both phosphatidylinositol 3-kinase and mammalian target of rapamycin as a therapeutic strategy for acute leukemia treatment
2012 Martelli, Am; Chiarini, F; Evangelisti, C; Cappellini, A; Buontempo, F; Bressanin, D; Fini, M; Mccubrey, Ja.
Temsirolimus, an mTOR inhibitor, in combination with lower-dose clofarabine as salvage therapy for older patients with acute myeloid leukaemia: results of a phase II GIMEMA study (AML-1107)
2012 Amadori, S.; Stasi, R.; Martelli, Alberto Maria; Venditti, A.; Meloni, G.; Pane, F.; Martinelli, Giovanni; Lunghi, M.; Pagano, L.; Cilloni, D.; Rossetti, E.; Di Raimondo, F.; Fozza, C.; Annino, L.; Chiarini, Francesca; Ricci, F.; Ammatuna, E.; La Sala, E.; Fazi, P.; Vignetti, M.
The cyclin-dependent kinase inhibitor roscovitine and the nucleoside analog sangivamycin induce apoptosis in caspase-3 deficient breast cancer cells independent of caspase mediated P-glycoprotein cleavage
2009 A., Cappellini; Chiarini, Francesca; A., Ognibene; J. A., Mccubrey; Martelli, Alberto Maria
Dual Inhibition of Phosphatidylinositol 3-Kinase and Mammalian Target of Rapamycin: a Therapeutic Strategy for Acute Leukemias
2012 Chiarini, F; Evangelisti, C; Buontempo, F; Bressanin, D; Fini, M; Cocco, L; Cappellini, A; Mccubrey, Ja; Martelli, Am.
Autophagy in acute leukemias: a double-edged sword with important therapeutic implications
2015 Evangelisti, C; Evangelisti, C; Chiarini, F; Lonetti, A; Buontempo, F; Neri, Lm; Mccubrey, Ja; Martelli, Am
Activity of the selective IκB kinase inhibitor BMS-345541 against T-cell acute lymphoblastic leukemia: involvement of FOXO3a
2012 Buontempo, F; Chiarini, F; Bressanin, D; Tabellini, G; Melchionda, F; Pession, A; Fini, M; Neri, Lm; Mccubrey, Ja; Martelli, Am.
AMP-dependent kinase/mammalian target of rapamycin complex 1 signaling in T-cell acute lymphoblastic leukemia: therapeutic implications
2012 Grimaldi, Cecilia; Chiarini, Francesca; Tabellini, G.; Ricci, F.; Tazzari, P. L.; Battistelli, M.; Falcieri, E.; Bortul, R.; Melchionda, F.; Iacobucci, Ilaria; Pagliaro, P.; Martinelli, Giovanni; Pession, Andrea; Barata, J. T.; Mccubrey, J. A.; Martelli, Alberto Maria
Therapeutic potential of targeting sphingosine kinases and sphingosine 1-phosphate in hematological malignancies
2016 Evangelisti, C; Evangelisti, C; Buontempo, F; Lonetti, A; Orsini, E; Chiarini, F; Barata, Jt; Pyne, S; Pyne, Nj; Martelli, Am.
Therapeutic targeting of Polo-like kinase-1 and Aurora kinases in T-cell acute lymphoblastic leukemia
2014 Spartà, Am; Bressanin, D; Chiarini, F; Lonetti, A; Cappellini, A; Evangelisti, C; Evangelisti, C; Melchionda, F; Pession, A; Bertaina, A; Locatelli, F; Mccubrey, Ja; Martelli, Am.
Advances in understanding the acute lymphoblastic leukemia bone marrow microenvironment: From biology to therapeutic targeting
2016 Chiarini, F; Lonetti, A; Evangelisti, C; Buontempo, F; Orsini, E; Evangelisti, C; Cappellini, A; Neri, Lm; Mccubrey, Ja; Martelli, Am
Targeting the liver kinase B1/AMP-activated protein kinase pathway as a therapeutic strategy for hematological malignancies
2012 Martelli, Am; Chiarini, F; Evangelisti, C; Ognibene, A; Bressanin, D; Billi, Am; Manzoli, L; Cappellini, A; Mccubrey, Ja.
The phosphatidylinositol 3-kinase/Akt/mTOR signaling network as a therapeutic target in acute myelogenous leukemia patients
2010 Martelli, Alberto Maria; Evangelisti, Camilla; Chiarini, Francesca; J. A., Mccubrey
Targeting Wnt/β-catenin and PI3K/Akt/mTOR pathways in T-cell acute lymphoblastic leukemia
2020 Evangelisti, C; Chiarini, F; Cappellini, A; Paganelli, F; Fini, M; Santi, S; Martelli, Am; Neri, Lm; Evangelisti, C.
The phosphatidylinositol 3-kinase/AKT/mammalian target of rapamycin signaling network and the control of normal myelopoiesis
2010 Martelli, Alberto Maria; Chiarini, Francesca; Evangelisti, Camilla; Grimaldi, Cecilia; Ognibene, A; Manzoli, Lucia; Billi, Anna Maria; Mccubrey, Ja
Synergistic proapoptotic activity of recombinant TRAIL plus the Akt inhibitor perifosine in acute myeloid leukemia cells
2008 Tazzari, P. L.; Tabellini, Giovanna; Ricci, F.; Papa, Veronica; Bortul, R.; Chiarini, Francesca; Evangelisti, Camilla; Martinelli, Giovanni; Bontadini, A.; Cocco, Lucio Ildebrando; Mccubrey, J. A.; Martelli, Alberto Maria
Therapeutic potential of targeting mTOR in T-cell acute lymphoblastic leukemia (Review)
2014 Evangelisti, C; Evangelisti, C; Chiarini, F; Lonetti, A; Buontempo, F; Bressanin, D; Cappellini, A; Orsini, E; Mccubrey, Ja; Martelli, Am.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Phosphatidylinositol 3-kinase inhibition potentiates glucocorticoid response in B-cell acute lymphoblastic leukemia | 1-gen-2018 | Evangelisti, C; Cappellini, A; Oliveira, M; Fragoso, R; Barata, Jt; Bertaina, A; Locatelli, F; Simioni, C; Neri, Lm; Chiarini, F; Lonetti, A; Buontempo, F; Orsini, E; Pession, A; Manzoli, L; Martelli, Am; Evangelisti, C. | |
| Age-Related Alterations Affecting the Chondrogenic Differentiation of Synovial Fluid Mesenchymal Stromal Cells in an Equine Model | 1-gen-2019 | Mazzotti, E; Teti, G; Falconi, M; Chiarini, F; Barboni, B; Mazzotti, A; Muttini, A. | |
| Enhancing the effectiveness of nucleoside analogs with mTORC1 blockers to treat acute myeloid leukemia patients | 1-gen-2013 | Martelli, Am; Lonetti, A; Amadori, S; Mccubrey, Ja; Chiarini, F | |
| Therapeutic targeting of CK2 in acute and chronic leukemias | 1-gen-2018 | Buontempo, F; Mccubrey, Ja; Orsini, E; Ruzzene, M; Cappellini, A; Lonetti, A; Evangelisti, C; Chiarini, F; Evangelisti, C; Barata, Jt; Martelli, Am. | |
| Two hits are better than one: targeting both phosphatidylinositol 3-kinase and mammalian target of rapamycin as a therapeutic strategy for acute leukemia treatment | 1-gen-2012 | Martelli, Am; Chiarini, F; Evangelisti, C; Cappellini, A; Buontempo, F; Bressanin, D; Fini, M; Mccubrey, Ja. | |
| Temsirolimus, an mTOR inhibitor, in combination with lower-dose clofarabine as salvage therapy for older patients with acute myeloid leukaemia: results of a phase II GIMEMA study (AML-1107) | 1-gen-2012 | Amadori, S.; Stasi, R.; Martelli, Alberto Maria; Venditti, A.; Meloni, G.; Pane, F.; Martinelli, Giovanni; Lunghi, M.; Pagano, L.; Cilloni, D.; Rossetti, E.; Di Raimondo, F.; Fozza, C.; Annino, L.; Chiarini, Francesca; Ricci, F.; Ammatuna, E.; La Sala, E.; Fazi, P.; Vignetti, M. | |
| The cyclin-dependent kinase inhibitor roscovitine and the nucleoside analog sangivamycin induce apoptosis in caspase-3 deficient breast cancer cells independent of caspase mediated P-glycoprotein cleavage | 1-gen-2009 | A., Cappellini; Chiarini, Francesca; A., Ognibene; J. A., Mccubrey; Martelli, Alberto Maria | |
| Dual Inhibition of Phosphatidylinositol 3-Kinase and Mammalian Target of Rapamycin: a Therapeutic Strategy for Acute Leukemias | 1-gen-2012 | Chiarini, F; Evangelisti, C; Buontempo, F; Bressanin, D; Fini, M; Cocco, L; Cappellini, A; Mccubrey, Ja; Martelli, Am. | |
| Autophagy in acute leukemias: a double-edged sword with important therapeutic implications | 1-gen-2015 | Evangelisti, C; Evangelisti, C; Chiarini, F; Lonetti, A; Buontempo, F; Neri, Lm; Mccubrey, Ja; Martelli, Am | |
| Activity of the selective IκB kinase inhibitor BMS-345541 against T-cell acute lymphoblastic leukemia: involvement of FOXO3a | 1-gen-2012 | Buontempo, F; Chiarini, F; Bressanin, D; Tabellini, G; Melchionda, F; Pession, A; Fini, M; Neri, Lm; Mccubrey, Ja; Martelli, Am. | |
| AMP-dependent kinase/mammalian target of rapamycin complex 1 signaling in T-cell acute lymphoblastic leukemia: therapeutic implications | 1-gen-2012 | Grimaldi, Cecilia; Chiarini, Francesca; Tabellini, G.; Ricci, F.; Tazzari, P. L.; Battistelli, M.; Falcieri, E.; Bortul, R.; Melchionda, F.; Iacobucci, Ilaria; Pagliaro, P.; Martinelli, Giovanni; Pession, Andrea; Barata, J. T.; Mccubrey, J. A.; Martelli, Alberto Maria | |
| Therapeutic potential of targeting sphingosine kinases and sphingosine 1-phosphate in hematological malignancies | 1-gen-2016 | Evangelisti, C; Evangelisti, C; Buontempo, F; Lonetti, A; Orsini, E; Chiarini, F; Barata, Jt; Pyne, S; Pyne, Nj; Martelli, Am. | |
| Therapeutic targeting of Polo-like kinase-1 and Aurora kinases in T-cell acute lymphoblastic leukemia | 1-gen-2014 | Spartà, Am; Bressanin, D; Chiarini, F; Lonetti, A; Cappellini, A; Evangelisti, C; Evangelisti, C; Melchionda, F; Pession, A; Bertaina, A; Locatelli, F; Mccubrey, Ja; Martelli, Am. | |
| Advances in understanding the acute lymphoblastic leukemia bone marrow microenvironment: From biology to therapeutic targeting | 1-gen-2016 | Chiarini, F; Lonetti, A; Evangelisti, C; Buontempo, F; Orsini, E; Evangelisti, C; Cappellini, A; Neri, Lm; Mccubrey, Ja; Martelli, Am | |
| Targeting the liver kinase B1/AMP-activated protein kinase pathway as a therapeutic strategy for hematological malignancies | 1-gen-2012 | Martelli, Am; Chiarini, F; Evangelisti, C; Ognibene, A; Bressanin, D; Billi, Am; Manzoli, L; Cappellini, A; Mccubrey, Ja. | |
| The phosphatidylinositol 3-kinase/Akt/mTOR signaling network as a therapeutic target in acute myelogenous leukemia patients | 1-gen-2010 | Martelli, Alberto Maria; Evangelisti, Camilla; Chiarini, Francesca; J. A., Mccubrey | |
| Targeting Wnt/β-catenin and PI3K/Akt/mTOR pathways in T-cell acute lymphoblastic leukemia | 1-gen-2020 | Evangelisti, C; Chiarini, F; Cappellini, A; Paganelli, F; Fini, M; Santi, S; Martelli, Am; Neri, Lm; Evangelisti, C. | |
| The phosphatidylinositol 3-kinase/AKT/mammalian target of rapamycin signaling network and the control of normal myelopoiesis | 1-gen-2010 | Martelli, Alberto Maria; Chiarini, Francesca; Evangelisti, Camilla; Grimaldi, Cecilia; Ognibene, A; Manzoli, Lucia; Billi, Anna Maria; Mccubrey, Ja | |
| Synergistic proapoptotic activity of recombinant TRAIL plus the Akt inhibitor perifosine in acute myeloid leukemia cells | 1-gen-2008 | Tazzari, P. L.; Tabellini, Giovanna; Ricci, F.; Papa, Veronica; Bortul, R.; Chiarini, Francesca; Evangelisti, Camilla; Martinelli, Giovanni; Bontadini, A.; Cocco, Lucio Ildebrando; Mccubrey, J. A.; Martelli, Alberto Maria | |
| Therapeutic potential of targeting mTOR in T-cell acute lymphoblastic leukemia (Review) | 1-gen-2014 | Evangelisti, C; Evangelisti, C; Chiarini, F; Lonetti, A; Buontempo, F; Bressanin, D; Cappellini, A; Orsini, E; Mccubrey, Ja; Martelli, Am. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- Contributo su RIVISTA69852
- Atti di CONVEGNO1
- Contributo su VOLUME1
Data di pubblicazione
- 2020 - 202720193
- 2010 - 201923511
- 2000 - 200914315
- 1990 - 19998032
- 1980 - 19893149
- 1970 - 1979640
- 1966 - 196911
Editore
- Elsevier BV:PO Box 211, 1000 AE A...334
- American Institute of Physics:2 H...226
- Elsevier Science Limited:Oxford F...189
- Giuffre Editore Spa:via Busto Ars...101
- Societa Editrice il Mulino Spa:St...73
- Springer Verlag Germany:Tiergarte...71
- IEEE / Institute of Electrical an...70
- Academic Press Incorporated:6277 ...67
- American Chemical Society:1155 Si...63
- Edizioni Minerva Medica:Corso Bra...59
Rivista
- JOURNAL OF HIGH ENERGY PHYSICS404
- EFSA JOURNAL380
- PLOS ONE315
- PHYSICAL REVIEW LETTERS309
- PHYSICAL REVIEW. B, CONDENSED MAT...294
- SCIENTIFIC REPORTS290
Serie
- EUROPEAN DISTANCE AND E-LEARNING ...1
Keyword
- Humans4564
- Female2681
- Male2251
- Middle Aged1673
- Adult1526
- Aged1328
- Italy767
- Treatment Outcome649
- COVID-19587
- 80 and over506
Lingua
- eng58328
- ita10772
- fre334
- spa299
- ger189
- por61
- rus24
- und23
- chi15
- pol6
Accesso al fulltext
- no fulltext29929
- open19774
- reserved18695
- partially open1440
- embargoed15
- mixed1
